These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 18705817

  • 1. Dual renin-angiotensin system blockade: on the target.
    Robles NR.
    Int J Clin Pract; 2008 Aug; 62(8):1134-6. PubMed ID: 18705817
    [No Abstract] [Full Text] [Related]

  • 2. Dual blockade of renin-angiotensin system in primary focal segmental glomerulosclerosis.
    Singh A.
    Nephrol Dial Transplant; 2006 Mar; 21(3):830-1. PubMed ID: 16278255
    [No Abstract] [Full Text] [Related]

  • 3. Combination renin-angiotensin system blockade in hypertension.
    Doulton TW, Macgregor GA.
    Kidney Int; 2005 Oct; 68(4):1898. PubMed ID: 16164672
    [No Abstract] [Full Text] [Related]

  • 4. Dual renin-angiotensin system blockade in heart failure.
    McMurray JJ, Granger CB, Ostergren J, Yusuf S, Pfeffer MA, Swedberg K.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):278; author reply 279-80. PubMed ID: 19589444
    [No Abstract] [Full Text] [Related]

  • 5. Dual renin-angiotensin system blockade and kidney disease.
    Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Pfeffer MA.
    J Am Coll Cardiol; 2009 Jul 14; 54(3):278-9; author reply 279-80. PubMed ID: 19589445
    [No Abstract] [Full Text] [Related]

  • 6. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK.
    Rev Cardiovasc Med; 2007 Jul 14; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [Abstract] [Full Text] [Related]

  • 7. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
    Hirsch S.
    Int J Clin Pract; 2010 Sep 14; 64(10):1337-40. PubMed ID: 20716140
    [No Abstract] [Full Text] [Related]

  • 8. Renin inhibition: what are the clinical perspectives?
    Hollenberg NK.
    Semin Nephrol; 2007 Sep 14; 27(5):511-8. PubMed ID: 17868787
    [Abstract] [Full Text] [Related]

  • 9. Is there added value to adding ARB to ACE inhibitors in the management of CKD?
    Cohen DL, Townsend RR.
    J Am Soc Nephrol; 2009 Aug 14; 20(8):1666-8. PubMed ID: 18776118
    [Abstract] [Full Text] [Related]

  • 10. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M, Franchini M, Fanos V.
    Pharmacotherapy; 2008 Jan 14; 28(1):125-30. PubMed ID: 18154482
    [Abstract] [Full Text] [Related]

  • 11. Rationale for combining blockers of the renin-angiotensin system.
    Azizi M, Wuerzner G.
    Semin Nephrol; 2007 Sep 14; 27(5):544-54. PubMed ID: 17868792
    [Abstract] [Full Text] [Related]

  • 12. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
    Hollenberg NK, Epstein M.
    Clin J Am Soc Nephrol; 2006 Sep 14; 1(5):1046-8. PubMed ID: 17699325
    [No Abstract] [Full Text] [Related]

  • 13. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
    Mann JF, McClellan WM, Kunz R, Ritz E.
    Nephrol Dial Transplant; 2006 Sep 14; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
    [No Abstract] [Full Text] [Related]

  • 14. The hazards of dual renin-angiotensin blockade in chronic kidney disease.
    Ku E, Park J, Vidhun J, Campese V.
    Arch Intern Med; 2009 Jun 08; 169(11):1015-8. PubMed ID: 19506167
    [No Abstract] [Full Text] [Related]

  • 15. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J.
    Nefrologia; 2004 Jun 08; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract] [Full Text] [Related]

  • 16. [Atrial fibrillation: potential therapeutic interventions in the renin-angiotensin-aldosterone system].
    Dabrowski R, Szwed H.
    Kardiol Pol; 2007 Apr 08; 65(4):440-5. PubMed ID: 17530565
    [No Abstract] [Full Text] [Related]

  • 17. [High risk arterial hypertension: the role of angiotensin II receptor blockers].
    Fomin VV, Moiseev SV, Mukhin NA.
    Ter Arkh; 2007 Apr 08; 79(10):86-91. PubMed ID: 18154154
    [No Abstract] [Full Text] [Related]

  • 18. RAAS inhibition/blockade in patients with cardiovascular disease: implications of recent large-scale randomised trials for clinical practice.
    Pitt B.
    Heart; 2009 Aug 08; 95(15):1205-8. PubMed ID: 19401281
    [No Abstract] [Full Text] [Related]

  • 19. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
    Berl T.
    Nephrol Dial Transplant; 2008 Aug 08; 23(8):2443-7. PubMed ID: 18467376
    [No Abstract] [Full Text] [Related]

  • 20. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
    Ram CV, Deedwania PC.
    Am J Cardiol; 2008 Nov 01; 102(9):1281-3. PubMed ID: 18940307
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.